Bourne Partners Strategic Capital and Meeting Street Capital Lead Series A in Cadence Rx
October 29, 2020
Bourne Partners Strategic Capital (BPSC) and Meeting Street Capital (MSC) jointly led a Series A growth equity investment in Cadence Rx, a workers' compensation-focused pharmacy benefit manager (PBM) founded by Artemis Emslie. The funding will support scaling Cadence Rx's tech-enabled PBM platform to reduce drug spend and expand program management for workers' compensation carriers, third-party administrators, self-insured employers and state-run enterprises.
- Buyers
- Bourne Partners Strategic Capital, Meeting Street Capital
- Targets
- Cadence Rx
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.